1. Home
  2. CRMN vs GTBP Comparison

CRMN vs GTBP Comparison

Compare CRMN & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CRMN

Skyline Builders Group Holding Limited Class A Ordinary Shares

N/A

Current Price

$1.01

Market Cap

15.0M

ML Signal

N/A

Logo GT Biopharma Inc.

GTBP

GT Biopharma Inc.

SELL

Current Price

$3.30

Market Cap

12.4M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CRMN
GTBP
Founded
2024
1965
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.0M
12.4M
IPO Year
2024
2016

Fundamental Metrics

Financial Performance
Metric
CRMN
GTBP
Price
$1.01
$3.30
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 1.1M
72.7K
Earning Date
N/A
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.62
$0.22
52 Week High
$0.82
$236.00

Technical Indicators

Market Signals
Indicator
CRMN
GTBP
Relative Strength Index (RSI) N/A 25.75
Support Level N/A $0.22
Resistance Level N/A $7.50
Average True Range (ATR) 0.00 0.39
MACD 0.00 0.09
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
CRMN
GTBP

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.

Share on Social Networks: